PAX8 and ovarian carcinoma: Similarly, ASRGL1 (asparaginase like 1) is highly expressed in ovarian carcinoma and confers a selective growth advantage [74]; accordingly, our data show that ASRGL1 is preferentially expressed in SKOV-3 cells where it is downregulated following PAX8 silencing (Table 3A).